No connection

Search Results

GOCO vs GSIW

GOCO
GoHealth, Inc.
BEARISH
Price
$1.05
Market Cap
$30.3M
Sector
Financial Services
AI Confidence
95%
GSIW
Garden Stage Limited
BEARISH
Price
$18.81
Market Cap
$26.6M
Sector
Financial Services
AI Confidence
90%

Valuation

P/E Ratio
GOCO
--
GSIW
--
Forward P/E
GOCO
-0.27
GSIW
--
P/B Ratio
GOCO
0.45
GSIW
1.03
P/S Ratio
GOCO
0.08
GSIW
3.29
EV/EBITDA
GOCO
-7.68
GSIW
--

Profitability

Gross Margin
GOCO
73.43%
GSIW
5.34%
Operating Margin
GOCO
-252.92%
GSIW
-192.19%
Profit Margin
GOCO
-71.06%
GSIW
-93.2%
ROE
GOCO
-219.72%
GSIW
-56.34%
ROA
GOCO
-7.72%
GSIW
-31.39%

Growth

Revenue Growth
GOCO
-96.8%
GSIW
414.6%
Earnings Growth
GOCO
--
GSIW
--

Financial Health

Debt/Equity
GOCO
--
GSIW
0.01
Current Ratio
GOCO
2.02
GSIW
2.51
Quick Ratio
GOCO
1.93
GSIW
1.34

Dividends

Dividend Yield
GOCO
--
GSIW
--
Payout Ratio
GOCO
0.0%
GSIW
0.0%

AI Verdict

GOCO BEARISH

GOCO exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9, indicating a near-total failure of fundamental health metrics. The company is experiencing a catastrophic collapse in top-line performance with YoY revenue growth plummeting -96.80% and an operating margin of -252.92%. While the stock trades at a deep discount to book value (P/B 0.45) and sales (P/S 0.08), these appear to be value traps given the trajectory of the business. Despite a bullish analyst target of $4.70, the deterministic data suggests a company in a death spiral with a -99.4% five-year price return.

Strengths
Low Price-to-Book ratio (0.45) suggesting deep value if assets are recoverable
Extremely low Price-to-Sales ratio (0.08)
Strong Gross Margin (73.43%) indicating the core service is still priced well
Risks
Catastrophic revenue decline of -96.80% YoY
Severe operational inefficiency with an operating margin of -252.92%
Extreme negative Return on Equity (ROE) of -219.72%
GSIW BEARISH

GSIW presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a complete lack of deterministic value anchors like the Graham Number. While the company shows explosive YoY revenue growth of 414.60%, this is offset by catastrophic profitability metrics, including a profit margin of -93.20% and an operating margin of -192.20%. The stock's long-term price performance is devastating, with a 99.1% decline over five years, and technical trends remain entirely bearish. Despite a clean balance sheet with very low debt, the company is currently unable to monetize its growth into earnings.

Strengths
Explosive YoY revenue growth of 414.60%
Very low leverage with a Debt/Equity ratio of 0.01
Strong short-term liquidity (Current Ratio: 2.51)
Risks
Severe operational losses with a -192.20% operating margin
Catastrophic long-term shareholder value destruction (-99.1% 5Y change)
Extreme price volatility (52-week range from $8 to $358)

Compare Another Pair

GOCO vs GSIW: Head-to-Head Comparison

This page compares GoHealth, Inc. (GOCO) and Garden Stage Limited (GSIW) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile